Insider Trades59 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | Sell | EBS | Paul Anthony Williams | SVP, Products Business | 3,000 | $8.40 | $393.7M | -45.73% | +35.89% | $25.2K | -1.85% | — | Trim |
| Jun 8, 2026 | Sell | EBS | Paul Anthony Williams | SVP, Products Business | 694 | $8.00 | $393.7M | -45.73% | +35.89% | $5.6K | -0.43% | — | Trim |
| Jun 8, 2026 | Sell | EBS | William Hartzel | SVP, Bioservices | 1,741 | $8.00 | $393.7M | -45.73% | +35.89% | $13.9K | -0.93% | — | Trim |
| Jun 8, 2026 | Sell | EBS | Coleen Glessner | EVP, Quality & Ethics, and CPL | 2,018 | $8.00 | $393.7M | -45.73% | +35.89% | $16.1K | -0.99% | — | Trim |
| Jun 8, 2026 | Sell | EBS | Richard S Lindahl | EVP, Chief Financial Officer | 3,964 | $8.00 | $393.7M | -45.73% | +35.89% | $31.7K | -1.05% | — | Trim |
| Apr 1, 2026 | Sell | EBS | Paul Anthony Williams | SVP, Products Business | 4,000 | $8.44 | $393.7M | -45.73% | +35.89% | $33.8K | -6.00% | — | Trim |
| Mar 5, 2026 | Sell | EBS | Jessica Perl | SVP, General Counsel, Corp Sec | 6,465 | $8.44 | $393.7M | -45.73% | +35.89% | $54.6K | -3.08% | — | Trim |
| Mar 5, 2026 | Sell | EBS | Coleen Glessner | EVP, Quality & Ethics, and CPL | 8,199 | $8.44 | $393.7M | -45.73% | +35.89% | $69.2K | -2.02% | — | Trim |
| Mar 5, 2026 | Sell | EBS | Paul Anthony Williams | SVP, Products Business | 9,397 | $8.44 | $393.7M | -45.73% | +35.89% | $79.3K | -2.84% | — | Trim |
| Mar 5, 2026 | Sell | EBS | William Hartzel | SVP, Bioservices | 9,493 | $8.44 | $393.7M | -45.73% | +35.89% | $80.1K | -2.66% | — | Trim |
| Mar 5, 2026 | Sell | EBS | Simon C Lowry | SVP, R&D, CMO | 10,636 | $8.44 | $393.7M | -45.73% | +35.89% | $89.8K | -4.50% | — | Trim |
| Mar 5, 2026 | Sell | EBS | Richard S Lindahl | EVP, Chief Financial Officer | 23,650 | $8.44 | $393.7M | -45.73% | +35.89% | $199.6K | -2.97% | — | Trim |
| Mar 5, 2026 | Sell | EBS | Joseph C Papa | President and CEO | 37,055 | $8.44 | $393.7M | -45.73% | +35.89% | $312.7K | -1.74% | — | Trim |
| Mar 1, 2026 | Sell | EBS | Paul Anthony Williams | SVP, Products Business | 116 | $8.15 | $393.7M | -45.73% | +35.89% | $945.4 | -0.15% | — | Trim |
| Mar 1, 2026 | Sell | EBS | Coleen Glessner | EVP, Quality & Ethics, and CPL | 313 | $8.15 | $393.7M | -45.73% | +35.89% | $2.6K | -0.28% | — | Trim |
| Mar 1, 2026 | Sell | EBS | Richard S Lindahl | EVP, Chief Financial Officer | 683 | $8.15 | $393.7M | -45.73% | +35.89% | $5.6K | -0.28% | — | Trim |
| Feb 9, 2026 | Sell | EBS | Jessica Perl | SVP, General Counsel, Corp Sec | 918 | $11.03 | $393.7M | -45.73% | +35.89% | $10.1K | -1.34% | — | Trim |
| Feb 6, 2026 | Sell | EBS | William Hartzel | SVP, Bioservices | 630 | $10.92 | $393.7M | -45.73% | +35.89% | $6.9K | -0.65% | — | Trim |
| Feb 6, 2026 | Sell | EBS | Paul Anthony Williams | SVP, Products Business | 1,022 | $10.92 | $393.7M | -45.73% | +35.89% | $11.2K | -1.32% | — | Trim |
| Feb 6, 2026 | Sell | EBS | Coleen Glessner | EVP, Quality & Ethics, and CPL | 2,852 | $10.92 | $393.7M | -45.73% | +35.89% | $31.1K | -2.47% | — | Trim |
| Feb 6, 2026 | Sell | EBS | Richard S Lindahl | EVP, Chief Financial Officer | 5,642 | $10.92 | $393.7M | -45.73% | +35.89% | $61.6K | -2.30% | — | Trim |
| Dec 14, 2025 | Sell | EBS | Simon C Lowry | SVP, R&D, CMO | 3,543 | $11.41 | $393.7M | -45.73% | +35.89% | $40.4K | -3.85% | — | Trim |
| Nov 11, 2025 | Sell | EBS | William Hartzel | SVP, Bioservices | 610 | $10.88 | $393.7M | -45.73% | +35.89% | $6.6K | -0.59% | — | Trim |
| Oct 15, 2025 | Sell | EBS | Richard S Lindahl | EVP, Chief Financial Officer | 4,995 | $9.60 | $393.7M | -45.73% | +35.89% | $48.0K | -1.68% | — | Trim |
| Oct 7, 2025 | Sell | EBS | Coleen Glessner | EVP, Quality & Ethics, and CPL | 30,608 | $10.00 | $393.7M | -45.73% | +35.89% | $306.1K | -17.50% | — | Trim |
| Jul 11, 2025 | Sell | EBS | William Hartzel | SVP, Bioservices | 4,263 | $7.36 | $393.7M | -45.73% | +35.89% | $31.4K | -3.95% | — | Trim |
| Jun 8, 2025 | Sell | EBS | Paul Anthony Williams | SVP, Products Business | 464 | $6.63 | $393.7M | -45.73% | +35.89% | $3.1K | -0.54% | — | Trim |
| Jun 8, 2025 | Sell | EBS | William Hartzel | SVP, Bioservices | 1,167 | $6.63 | $393.7M | -45.73% | +35.89% | $7.7K | -1.07% | — | Trim |
| Jun 8, 2025 | Sell | EBS | Coleen Glessner | EVP, Quality & Ethics, and CPL | 1,249 | $6.63 | $393.7M | -45.73% | +35.89% | $8.3K | -0.71% | — | Trim |
| Jun 8, 2025 | Sell | EBS | Richard S Lindahl | EVP, Chief Financial Officer | 2,733 | $6.63 | $393.7M | -45.73% | +35.89% | $18.1K | -0.91% | — | Trim |
| May 13, 2025 | Buy | EBS | Joseph C Papa | President and CEO | 60,000 | $5.83 | $393.7M | -45.73% | +35.89% | $349.8K | +21.24% | — | Trim |
| Apr 7, 2025 | Sell | EBS | Coleen Glessner | EVP, Quality & Ethics, and CPL | 480 | $4.44 | $393.7M | -45.73% | +35.89% | $2.1K | -0.27% | — | Trim |
| Apr 7, 2025 | Sell | EBS | William Hartzel | SVP, Bioservices | 561 | $4.44 | $393.7M | -45.73% | +35.89% | $2.5K | -0.51% | — | Trim |
| Mar 5, 2025 | Sell | EBS | William Hartzel | SVP, Bioservices | 292 | $5.80 | $393.7M | -45.73% | +35.89% | $1.7K | -0.62% | — | Trim |
| Mar 1, 2025 | Sell | EBS | Coleen Glessner | EVP, Quality & Ethics, and CPL | 313 | $7.48 | $393.7M | -45.73% | +35.89% | $2.3K | -0.27% | — | Trim |
| Feb 28, 2025 | Sell | EBS | Paul Anthony Williams | SVP, Products Business | 498 | $7.48 | $393.7M | -45.73% | +35.89% | $3.7K | -1.03% | — | Trim |
| Feb 28, 2025 | Sell | EBS | Richard S Lindahl | EVP, Chief Financial Officer | 1,756 | $7.48 | $393.7M | -45.73% | +35.89% | $13.1K | -0.57% | — | Trim |
| Feb 9, 2025 | Sell | EBS | Jessica Perl | SVP, General Counsel, Corp Sec | 918 | $10.00 | $393.7M | -45.73% | +35.89% | $9.2K | -13.49% | — | Trim |
| Dec 8, 2024 | Sell | EBS | Coleen Glessner | EVP, Quality & Ethics, and CPL | 18,674 | $9.01 | $393.7M | -45.73% | +35.89% | $168.3K | -11.45% | — | Trim |
| Nov 11, 2024 | Sell | EBS | William Hartzel | SVP, Bioservices | 632 | $11.97 | $393.7M | -45.73% | +35.89% | $7.6K | -1.31% | — | Trim |
| Jul 8, 2024 | Sell | EBS | Paul Anthony Williams | SVP, Products Business | 85 | $8.13 | $393.7M | -45.73% | +35.89% | $691.05 | -0.35% | — | Trim |
| Jun 8, 2024 | Sell | EBS | Paul Anthony Williams | SVP, Products Business | 464 | $6.19 | $393.7M | -45.73% | +35.89% | $2.9K | -1.86% | — | Trim |
| Jun 8, 2024 | Sell | EBS | William Hartzel | SVP, Bioservices | 1,167 | $6.19 | $393.7M | -45.73% | +35.89% | $7.2K | -3.40% | — | Trim |
| Jun 8, 2024 | Sell | EBS | Coleen Glessner | EVP, Quality & Ethics, and CPL | 1,249 | $6.19 | $393.7M | -45.73% | +35.89% | $7.7K | -0.76% | — | Trim |
| Jun 8, 2024 | Sell | EBS | Jennifer Lynne Fox | EVP, Ext Aff, GC, Corp Sec | 2,376 | $6.19 | $393.7M | -45.73% | +35.89% | $14.7K | -1.37% | — | Trim |
| Jun 8, 2024 | Sell | EBS | Richard S Lindahl | EVP, Chief Financial Officer | 2,733 | $6.19 | $393.7M | -45.73% | +35.89% | $16.9K | -1.72% | — | Trim |
| Apr 7, 2024 | Sell | EBS | Coleen Glessner | EVP, Quality & Ethics, and CPL | 585 | $2.29 | $393.7M | -45.73% | +35.89% | $1.3K | -0.35% | — | Trim |
| Apr 7, 2024 | Sell | EBS | William Hartzel | SVP, Bioservices | 665 | $2.29 | $393.7M | -45.73% | +35.89% | $1.5K | -1.90% | — | Trim |
| Mar 5, 2024 | Sell | EBS | William Hartzel | SVP, Bioservices | 346 | $3.41 | $393.7M | -45.73% | +35.89% | $1.2K | -0.98% | — | Trim |
| Mar 1, 2024 | Sell | EBS | Coleen Glessner | EVP, Quality & Ethics, and CPL | 381 | $3.39 | $393.7M | -45.73% | +35.89% | $1.3K | -0.23% | — | Trim |
| Feb 29, 2024 | Sell | EBS | Paul Anthony Williams | SVP, Products Business | 587 | $3.27 | $393.7M | -45.73% | +35.89% | $1.9K | -1.16% | — | Trim |
| Feb 29, 2024 | Sell | EBS | Jennifer Lynne Fox | EVP, Ext Aff, GC, Corp Sec | 4,806 | $3.25 | $393.7M | -45.73% | +35.89% | $15.6K | -1.36% | — | Trim |
| Feb 29, 2024 | Sell | EBS | Richard S Lindahl | EVP, Chief Financial Officer | 9,721 | $3.24 | $393.7M | -45.73% | +35.89% | $31.5K | -2.96% | — | Trim |
| Feb 23, 2024 | Sell | EBS | Paul Anthony Williams | SVP, Products Business | 105 | $2.74 | $393.7M | -45.73% | +35.89% | $287.7 | -0.41% | — | Trim |
| Feb 23, 2024 | Sell | EBS | Jennifer Lynne Fox | EVP, Ext Aff, GC, Corp Sec | 229 | $2.74 | $393.7M | -45.73% | +35.89% | $627.46 | -0.13% | — | Trim |
| Feb 23, 2024 | Sell | EBS | Richard S Lindahl | EVP, Chief Financial Officer | 517 | $2.74 | $393.7M | -45.73% | +35.89% | $1.4K | -0.31% | — | Trim |
| Nov 13, 2023 | Sell | EBS | Paul Anthony Williams | SVP, Products Business | 566 | $1.82 | $393.7M | -45.73% | +35.89% | $1.0K | -2.17% | — | Trim |
| Nov 11, 2023 | Sell | EBS | Jennifer Lynne Fox | EVP, Ext Aff, GC, Corp Sec | 413 | $2.00 | $393.7M | -45.73% | +35.89% | $826 | -0.23% | — | Trim |
| Nov 11, 2023 | Sell | EBS | William Hartzel | SVP, Bioservices | 632 | $2.00 | $393.7M | -45.73% | +35.89% | $1.3K | -1.76% | — | Trim |